| Line 2: |
Line 2: |
| | | | |
| | ====Description==== | | ====Description==== |
| | + | |
| | + | Equine protozoal myeloencephalitis |
| | + | Equine protozoal myeloencephalitis is caused by the protozoan |
| | + | Sarcocystis neurona and has only been seen in the |
| | + | UK in horses imported from the Americas. S neurona produces |
| | + | signs relating to diffuse, focal and multifocal lesions |
| | + | of the white and grey matter of the spinal cord and brain. |
| | + | Horses may present with ataxia or paresis of one or more |
| | + | limbs, manifest as stumbling, falling, knuckling and toe |
| | + | dragging. Sacrococcygeal involvement can result in signs |
| | + | of involvement of the cauda equina, thus mimicking |
| | + | polyneuritis equi. In addition, signs relating to involvement |
| | + | of the cranial nerves may be evident, producing signs such |
| | + | as loss of tongue tone, loss of sensation to the face and unilateral |
| | + | facial paralysis. With brain involvement, dysphagia, |
| | + | circling, head tilt or recumbency may be noted. |
| | + | At present, diagnosis is based on clinical signs and a |
| | + | previous history of importation from the Americas. With |
| | + | the recent isolation of the causative organism, laboratory |
| | + | diagnostic tests on serum and spinal fluid will become |
| | + | available in the future. Treatment involves the administration |
| | + | of trimethoprim/sulphadiazine (15 mg/kg orally |
| | + | twice daily) in combination with pyrimethamine (0-25 |
| | + | mg/kg orally once daily), both for at least six weeks. The |
| | + | prognosis is dependent on the severity and duration of |
| | + | neurological signs.(EPM 3) |
| | | | |
| | EQUINE protozoal myeloencephalitis (EPM) is a progressive | | EQUINE protozoal myeloencephalitis (EPM) is a progressive |